• Happy Holidays from Cafepharma! To allow its staff to spend holiday time with their families, the Cafepharma Message Boards will be switched to read-only from 6:00 PM Eastern time on Tuesday, December 24 until 10:00 PM Eastern time on Wednesday, December 25. During this time, all posts will be available for view. However, no one will be able to make new posts during this time.


allergan

  1. Ulipristal acetate to be reviewed by FDA

    Will this help out the 26 million women in U.S. who have got uterine fibroids?
  2. Shire sues Allergan. Who will win?

    After selling Restasis patent to Mohawk Indians, Allergan is playing against its opponent Shire. Shire's Xiidra vs. Allergan's Restasis. Who will win?
  3. Shire sues Allergan. Restasis vs. Xiidra

    After selling Restasis patent to Mohawk Indians, Allergan is playing the game very well.
  4. FDA to do priority review for Avycaz

    FDA to do a priority review for Avycaz and take action in first quarter of 2018.
  5. Senators ask for investigation on Mohawk Tribe deal

    Four senators, including Sherrod Brown ask for investigation on Mohawk Tribe deal.
  6. Tessa Hilado to retire

    Tessa Hilado to retire. Allergan is down 20% from the time she joined. Will any new CFO make Allergan profitable?
  7. Mvasi, first direct competitor to a billion-dollar cancer drug

    FDA approves Allergan and Amgen's biosimilar of Roche's Avastin.
  8. Allergan patent litigation

    Allergan reaches a settlement with Famy Care and it will grant Famy Care a license to market generic version of Restasis in U.S. in 2024.
  9. Sales Rep Interview Help

    Hoping to get some advice for my face to face with DM..any input will help.